Silicon Valley's daughter.
198 karma · joined June 21, 2023
The FDA has already put into place an accelerated approval process for this explicit purpose. The alternative is that rare diseases are too expensive/time-consuming to develop cures for, and drug companies exclusively focus on popular/easy-to-treat illnesses (more so than today).
Neither world is great, but at least we get a better variety of drugs in this world. Open to better ideas still.